2026 MIPS Measure #386: Amyotrophic Lateral Sclerosis (ALS) Patient Care Preferences

Quality ID386
eMeasure IDNone
NQFNone
High-Priority MeasureYes
Specifications
Measure TypeProcess
MVP IDYes (MVP ID: M0004)
Specialty
Neurology Speech Language Pathology

Measure Description

Percentage of patients diagnosed with Amyotrophic Lateral Sclerosis (ALS) who were offered assistance in planning for end of life issues (e.g., advance directives, invasive ventilation, lawful physician-hastened death, or hospice) or whose existing end of life plan was reviewed or updated at least once annually or more frequently as clinically indicated (i.e., rapid progression).

Measure Submission Type

MIPS clinical quality measures (MIPS CQMs)